Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
P Zatloukal, L Petruzelka, M Zemanova, L Havel… - Lung cancer, 2004 - Elsevier
Purpose: The superiority of chemoradiotherapy (CRT) over radiation alone in locally
advanced non-small cell lung cancer (NSCLC) has been proven, but the relative merits of a …
advanced non-small cell lung cancer (NSCLC) has been proven, but the relative merits of a …
Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non–small-cell lung cancer: Groupe …
P Fournel, G Robinet, P Thomas, PJ Souquet… - Journal of clinical …, 2005 - ascopubs.org
Purpose We conducted a phase III study to compare the survival impact of concurrent versus
sequential treatment with radiotherapy (RT) and chemotherapy (CT) in unresectable stage III …
sequential treatment with radiotherapy (RT) and chemotherapy (CT) in unresectable stage III …
Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer.
K Kubota, K Furuse, M Kawahara, N Kodama… - Journal of clinical …, 1994 - ascopubs.org
PURPOSE For patients with locally advanced (stage III) non-small-cell lung cancer
(NSCLC), radiotherapy (RT) has been used conventionally for many years. Few prospective …
(NSCLC), radiotherapy (RT) has been used conventionally for many years. Few prospective …
Randomised trial of sequential versus concurrent chemo-radiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)
J Belderbos, L Uitterhoeve, N van Zandwijk… - European journal of …, 2007 - Elsevier
A randomised phase III study was performed comparing sequential (S) and concurrent (C)
chemo-radiotherapy (CRT) in non-small cell lung cancer (NSCLC) patients. METHODS: One …
chemo-radiotherapy (CRT) in non-small cell lung cancer (NSCLC) patients. METHODS: One …
Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and …
RW Byhardt, C Scott, WT Sause, B Emami… - International Journal of …, 1998 - Elsevier
Purpose: The purpose of this study was to assess response, toxicity, failure patterns, and
survival differences in three chemotherapy (ChT)/radiation therapy (RT) sequencing …
survival differences in three chemotherapy (ChT)/radiation therapy (RT) sequencing …
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non–small-cell …
K Furuse, M Fukuoka, M Kawahara… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: A phase III study was performed to determine whether concurrent or sequential
treatment with radiotherapy (RT) and chemotherapy (CT) improves survival in unresectable …
treatment with radiotherapy (RT) and chemotherapy (CT) improves survival in unresectable …
Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation …
R Komaki, C Scott, D Ettinger, JS Lee… - International Journal of …, 1997 - Elsevier
Purpose: The purpose of this study was to compare the severity and distribution of the
toxicities associated with the two different combinations of chemotherapy and radiotherapy …
toxicities associated with the two different combinations of chemotherapy and radiotherapy …
GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and …
M Flentje, RM Huber, W Engel-Riedel… - Strahlentherapie …, 2016 - search.proquest.com
Background Concurrent chemoradiotherapy (CRT) is considered standard for inoperable
stage III non-small cell lung cancer (NSCLC). Consolidation chemotherapy (CC) following …
stage III non-small cell lung cancer (NSCLC). Consolidation chemotherapy (CC) following …
Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.
C Blanke, R Ansari, R Mantravadi, R Gonin… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE Here we report the results of a phase III study, to evaluate whether the addition of
cisplatin to radiation therapy (XRT) would improve progression-free survival or overall …
cisplatin to radiation therapy (XRT) would improve progression-free survival or overall …
Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer
SE Schild, WL McGinnis, D Graham, S Hillman… - International Journal of …, 2006 - Elsevier
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …
相关搜索
- small cell lung cancer
- sequential chemoradiotherapy cisplatin and vinorelbine
- lung cancer chemoradiotherapy alone
- lung cancer concurrent chemotherapy
- lung cancer escalating doses
- lung cancer modality treatment
- lung cancer combination with mitomycin
- lung cancer leukemia group
- lung cancer thoracic irradiation
- induction chemotherapy chemoradiotherapy alone
- lung cancer induction chemotherapy
- leukemia group chemoradiotherapy alone